Antitrust Antitrust

Japan's Alfresa, Suzuken, Toho Pharmaceutical face criminal charge over bid rigging on prescription drugs (Update*)

By Sachiko Sakamaki
  • 08 Dec 2020 22:56
  • 09 Dec 2020 18:54
Japan’s three major pharmaceutical wholesalers — Alfresa, Suzuken and Toho Pharmaceutical — are set to face criminal charges, along with seven of their executives, after the Japan Fair Trade Commission today filed a criminal complaint alleging bid rigging for prescription drugs that were procured by a public hospital operator.

The JFTC filed a criminal

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Sachiko Sakamaki

Senior Correspondent, Tokyo

Sachiko covers antitrust, mergers and acquisitions, privacy and data security, as well as patent disputes related to connected cars. She has an undergraduate degree from Waseda University in Tokyo and a master's degree in communications from United States International (now Alliant International) University in California. She previously worked as a journalist for Time magazine, the Far Eastern Economic Review, Bloomberg News, and the Washington Post in Japan.

Discover MLex

Stay on top of global regulatory developments


Latest News